Press release
Amerigo Scientific and Biontex Join Forces to Deliver Highly Efficient Transfection Reagents Coming with Detailed Selection Guide
Amerigo Scientific is pleased to establish a strategic alliance with Biontex Laboratories to deliver highly efficient transfection reagents.As a top distributor dedicated to offering critical products and services to the biomedical and life science communities, Amerigo Scientific is pleased to establish a strategic alliance with Biontex Laboratories to deliver highly efficient transfection kits [https://www.amerigoscientific.com/transfection-reagents.html].
In many research applications, such as gene expression studies, vaccine development, and gene therapy, transfection-the process of introducing nucleic acids into cells - is an essential step. Despite the advances in transfection technologies, choosing the appropriate reagents for particular cell types and experimental conditions can be difficult for scientists. Amerigo Scientific offers a range of top-tier transfection reagents and professional selection guidance to best suit clients' transfection experiments.
The premium transfection reagents from Amerigo Scientific are well-known for high effectiveness, minimal cytotoxicity, and versatility across a wide array of cell lines. As these reagents are engineered to optimize the cellular uptake of DNA, RNA, siRNA, and various types of nucleotides, researchers can obtain reliable transfection results with little effort. For instance, the K4 Registered Transfection Kit is particularly suitable for hard-to-transfect cells and allows transfecting of all types of nucleic acids. Additionally, to further support scientists in choosing the most suitable reagents for their experiments, Amerigo Scientific also offers a detailed transfection reagent buyer guide [https://www.amerigoscientific.com/transfection-reagent-selection-guide.html]. By outlining the optimal conditions for various cell types, this guide will help researchers make well-informed decisions and increase lab productivity.
"By collaborating with Biontex, we are excited to broaden our portfolio and provide value-added solutions to our clients," the marketing manager at Amerigo Scientific stated. "Our goal is to equip researchers with cutting-edge technologies that enhance their workflows and spur innovation in their respective domains. This partnership enables us to combine our strengths, leveraging Biontex's expertise in molecular biology with our commitment to providing top-notch scientific products. Together, we aim to accelerate advancements in research and support the scientific community in achieving groundbreaking discoveries."
About Amerigo Scientific
Amerigo Scientific, as a recognized distributor in the United States, collaborates closely with leading manufacturers worldwide and invites cooperation to all companies and institutions in the branch of reagents, kits, antibodies, and many other products for life science, biochemistry, and biotechnology. Its professional team is equipped with excellent technical support and thoughtful customer service. As most of its employees have earned a graduate (Ph.D. or M.S.) degree in life science, they can comprehend customers' questions or concerns and are always ready to provide individualized customer service of high standards.
Media Contact
Company Name: Amerigo Scientific
Contact Person: Phoebe Davis
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=amerigo-scientific-and-biontex-join-forces-to-deliver-highly-efficient-transfection-reagents-coming-with-detailed-selection-guide]
Country: United States
Website: https://www.amerigoscientific.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Amerigo Scientific and Biontex Join Forces to Deliver Highly Efficient Transfection Reagents Coming with Detailed Selection Guide here
News-ID: 3800334 • Views: …
More Releases from ABNewswire
Philip DeBerard Family Foundation Wins Judges Choice Award at 2025 Stuart Christ …
The Philip DeBerard Family Foundation, a community-focused nonprofit based in Stuart, Florida, captured statewide attention this holiday season after winning Judges Choice and the Large Float Classic Christmas Award at the Visiting Nurse Association of Florida Stuart Christmas Parade with its unforgettable and crowd-pleasing float titled "Grandma Got Run Over By a Brightline."
Presented during the annual Visiting Nurse Association of Florida 2025 Stuart Christmas Parade, the float featured a humorous,…
Growth Hormone Deficiency Market Insights Highlight Expanding Outlook Till 2034, …
The Key Growth Hormone Deficiency Companies in the market include - Novo Nordisk, Ascendis Pharma, Double Point Ventures (Lumos Pharma), SCOHIA PHARMA, and others.
The Growth Hormone Deficiency market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage pipeline products will significantly revolutionize the Growth Hormone Deficiency market dynamics.
DelveInsight's "Growth Hormone Deficiency Market Insights, Epidemiology, and Market Forecast-2034 report offers…
FDCTech, Inc. (OTC: FDCT) Poised to Capitalize on the Retail Trading Boom
Retail trading has emerged as a powerful force in global markets, with participation rising from roughly 25% of all trading activity in 2020 to over 30% by 2024. This surge has driven growing demand for social investing tools, copy trading features, and automated strategies, with analysts projecting these platforms could generate several billion dollars in annual revenue by the end of the decade.
At the same time, evolving regulatory frameworks, such…
Actinium Pharmaceuticals (NYSEAMERICAN: ATNM) Begins European Phase 1 Trial of N …
Innovation in oncology continues to accelerate, with global cancer R&D spending now exceeding hundreds of billions annually and more than a thousand new trials launched each year. Among the fastest-growing segments is radiopharmaceuticals, attracting significant investment as major pharmaceutical companies expand into precision radiation therapies. Growth has been fueled by strong clinical performance, improving isotope supply chains, and a wave of multibillion-dollar acquisitions that underscore investor confidence in targeted radiotherapy…
More Releases for Amerigo
Amerigo Scientific Launches Surface Functionalized Fluorescent Nanodiamonds, Mul …
Amerigo Scientific introduces the surface-functionalized fluorescent nanodiamonds (FNDs) featuring multiple particle sizes and custom functionalization.
New York, USA - October 29, 2025 - As a distributor committed to providing vital products and services to biomedical and life science communities, Amerigo Scientific introduces the surface-functionalized fluorescent nanodiamonds [https://www.amerigoscientific.com/surface-functionalized-fluorescent-nanodiamonds.html] (FNDs). This extensive range of products, featuring multiple particle sizes and custom functionalization, is in answer to the changing needs from biophysics, cell biology,…
Amerigo Scientific Announced Chromatography Media Ideal for Biomolecule Purifica …
Amerigo Scientific recently announced the collaboration with ISO 9001-certified manufacturers to distribute a wide range of chromatography media products.
New York, USA - November 14, 2024 - Amerigo Scientific recently announced the collaboration with ISO 9001-certified manufacturers to distribute a wide range of chromatography media products covering solid phase extraction adsorbents, silica gel, and resins. These chromatography media are manufactured with a proprietary production process, specializing in affinity, hydrophobic interaction, ion…
Amerigo Scientific Announces Ultra-Low Temperature Lab Freezers for Enhanced Sam …
Amerigo Scientific is thrilled to announce its latest innovation in sample preservation solution with the introduction of ultra-low temperature lab freezers.
New York, USA - August 21, 2024 - Amerigo Scientific, a distributor focused on providing critical products and services to biomedical and life science communities, is thrilled to announce its latest innovation in sample preservation solution with the introduction of ultra-low temperature lab freezers [https://www.amerigoscientific.com/instrument/86c-cascade-cooling-system-ultra-low-freezer-528-l-item-456668.html].
Image: https://www.getnews.info/uploads/388e75265b2298ba6a51ad5ab1e59e3c.jpg
Laboratory refrigerators and freezers are…
Amerigo Scientific Unveils Transfection Reagents Suitable for DNA and Protein De …
Amerigo Scientific, a distributor focused on providing critical products and services to biomedical and life science communities, is pleased to announce the launch of its latest line of transfection reagents [https://www.amerigoscientific.com/transfection-reagents.html] designed for the efficient delivery of DNA, siRNA, RNA, and proteins, powering up the transfection experiments for worldwide clients.
"We are excited to introduce our extensive transfection reagents to the research community," said the business manager at Amerigo Scientific. "Our…
Amerigo Scientific Releases Cyclic-di-GMP Assay to Simplify Cellular Function An …
Amerigo Scientific, a distributor focused on providing critical products and services to biomedical and life science communities, has announced the release of the cyclic-di-GMP assay used to streamline the analysis of cellular function by providing researchers with a simple and reliable method for detecting and quantifying the important signaling molecule cyclic-di-GMP.
Cyclic-di-GMP is a key regulator of bacterial physiology and plays a critical role in biofilm formation, virulence, and other cellular…
Amerigo Scientific Unveils CRISPR/Cas Enzymes to Expand the CRISPR Toolbox
Amerigo Scientific, as a distributor focused on providing critical products and services to biomedical and life science communities, announced the release of a groundbreaking selection of CRISPR/Cas enzymes to its extensive life science portfolio, aimed at further expanding the vast potential of the CRISPR toolbox. This addition brings cutting-edge genetic editing tools to scientists and researchers in a variety of fields.
CRISPR/Cas (Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-associated) technology revolutionized the…
